Log In
Print
BCIQ
Print
Print this Print this
 

benralizumab (KHK4563, MEDI-563) (formerly BIW-8405)

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionHumanized mAb against interleukin-5 (IL-5) receptor
Molecular Target Interleukin-5 (IL-5) receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today